1 in 8 Cancer Cases Are Linked to Infections: Why Vaccines Matter

Experts estimate that about one in eight cancer cases worldwide is linked to infection. The statistic highlights an often-overlooked fact: some cancers are not caused only by inherited genes, aging, or lifestyle. Long-lasting infections can also create conditions that allow cancer to develop.

Infections may promote cancer through chronic inflammation, repeated tissue damage, immune-system disruption, or interference with normal cellular controls. The risk usually develops over many years. An infection does not mean that a person will develop cancer, but persistent infection with certain pathogens can increase the likelihood.

Vaccination offers one practical way to reduce this risk. Human papillomavirus (HPV) and hepatitis B vaccines can prevent infections associated with several cancers. However, vaccines are not a universal cancer shield. Screening, testing, treatment, tobacco avoidance, safer behaviors, and regular medical care remain essential.

How Infections Can Lead to Cancer

Persistent Infections Can Change Cells Over Time

Many infections are temporary and are cleared by the immune system without lasting consequences. Cancer risk is more strongly associated with infections that persist for months or years.

Persistent infections can affect the body in several ways:

• Chronic inflammation can damage nearby tissue.
• Repeated injury and repair can create opportunities for abnormal cells to develop.
• Some pathogens interfere with normal cell-cycle controls.
• Long-term infection can alter immune responses.
• Certain infectious agents can contribute to changes in cellular DNA or the surrounding tissue environment.

These processes do not guarantee that cancer will develop. Cancer usually results from several interacting factors, including immune function, smoking, alcohol use, genetics, age, other medical conditions, and access to screening.

The International Agency for Research on Cancer identifies several infectious agents as carcinogenic to humans, including high-risk HPV types, hepatitis B virus, hepatitis C virus, and Helicobacter pylori (Source 1).

Cancer Risk Develops Over Years

Acquiring an infection and developing cancer are different events. A person may clear an infection, remain healthy despite a persistent infection, or receive treatment before serious damage occurs.

When infection-related cancer develops, it often follows a long period of inflammation or cellular change. This makes early prevention valuable even when its benefits are not immediately visible.

Vaccination works best before exposure. It trains the immune system to recognize a pathogen, reducing the chance of infection and, in some cases, preventing the persistent infection that can precede cancer.

The Main Infections Linked to Cancer

Human Papillomavirus and HPV-Related Cancers

HPV is a common viral infection transmitted through intimate skin-to-skin contact. Most HPV infections clear naturally. Some high-risk types, however, can persist and cause precancerous cellular changes.

Persistent high-risk HPV infection is associated with several cancers, including:

• Cervical cancer.
• Anal cancer.
• Penile cancer.
• Vulvar cancer.
• Vaginal cancer.
• Some cancers of the throat and mouth.

Cervical cancer is the clearest example of an HPV-related cancer that can often be prevented through vaccination and screening. HPV vaccination protects against the types most strongly associated with cancer and genital warts. The Centers for Disease Control and Prevention describes HPV vaccination as a safe and effective way to prevent HPV infections that can cause cancer (Source 2).

The vaccine does not treat an existing HPV infection, precancerous lesion, or cancer. It may still protect against HPV types a person has not encountered, depending on age and previous exposure. People who receive the vaccine should continue recommended cervical screening because vaccination does not eliminate every risk.

Hepatitis B and Liver Cancer

Hepatitis B is a viral infection that affects the liver. Many people recover from acute infection, but some develop chronic hepatitis B. Over time, chronic infection can cause inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma, the most common form of primary liver cancer.

Hepatitis B can spread through:

• Transmission from an infected parent to a newborn.
• Exposure to infected blood.
• Sexual contact.
• Shared needles or other blood-contaminated equipment.

Hepatitis B vaccination reduces the risk of infection and the long-term complications associated with chronic disease. Timely vaccination of newborns is particularly important because infection early in life is more likely to become chronic.

The World Health Organization recommends hepatitis B vaccination for all infants, beginning as soon as possible after birth, preferably within 24 hours (Source 3).

Vaccination cannot reverse chronic hepatitis B. People who may already have the infection need testing, medical assessment, and monitoring. Some require antiviral treatment to reduce the risk of liver damage and cancer.

Hepatitis C and Liver Cancer

Hepatitis C can also cause long-term liver inflammation, scarring, cirrhosis, and liver cancer. It is primarily transmitted through blood-to-blood exposure, including contaminated needles, unsafe medical equipment, or unscreened blood products where screening is incomplete.

No widely available hepatitis C vaccine currently exists. Prevention therefore depends on reducing blood exposure, testing people with possible exposure, and treating infection.

Modern antiviral medicines can cure most hepatitis C infections. Early diagnosis and treatment can prevent or reduce long-term liver damage. People with cirrhosis or other serious liver disease may need regular monitoring for liver cancer even after treatment.

Hepatitis C demonstrates why cancer prevention involves more than vaccination. Testing and effective treatment can also interrupt the pathway from chronic infection to cancer.

Helicobacter pylori and Stomach Cancer

Helicobacter pylori, commonly called H. pylori, is a bacterium that can infect the stomach lining. Persistent infection may cause chronic gastritis, peptic ulcers, and cellular changes that increase the risk of stomach cancer.

Most people with H. pylori do not develop cancer. Risk depends on factors such as the bacterial strain, family history, diet, smoking, inflammation, and the condition of the stomach lining.

There is no widely used H. pylori vaccine. Risk reduction may include:

• Medical testing when symptoms or risk factors warrant it.
• Antibiotic treatment when infection is confirmed.
• Follow-up care after treatment.
• Endoscopic monitoring for people at particularly high risk.

Treatment decisions should follow confirmed testing and professional guidance. Self-directed antibiotic use can fail to eradicate the infection and contribute to antibiotic resistance.

Other Infection-Related Cancer Risks

Other infectious agents are associated with selected cancers. These include Epstein-Barr virus, human T-cell leukemia virus type 1, Kaposi sarcoma-associated herpesvirus, and certain parasitic infections.

The strength of evidence and available prevention methods vary. Some infections have vaccines or effective treatments; others require screening, safer behaviors, infection control, or public-health measures.

Measles and influenza are important vaccine-preventable infections, but they should not be described as leading causes of infection-related cancer without strong supporting evidence. Their vaccines protect against severe infectious disease, complications, hospitalization, and community outbreaks rather than serving as direct vaccines against most cancers.

How Vaccines Help Prevent Cancer

Vaccines Prevent Infection Before Cancer Can Develop

Preventive vaccines train the immune system to identify a virus or other pathogen. The cancer-prevention pathway is indirect:

1. Vaccination lowers the chance of infection.
2. Fewer infections reduce the chance of persistent infection.
3. Fewer persistent infections reduce precancerous cellular changes.
4. Fewer precancerous changes reduce the risk of related cancers.

Protection is not absolute. A vaccinated person may still encounter a pathogen, and vaccines do not cover every cancer-causing strain or mechanism. They substantially reduce risk when used according to medical guidance.

HPV Vaccination and Cancer Prevention

HPV vaccination is most effective before exposure, which is why routine vaccination is recommended during adolescence. Schedules and catch-up recommendations vary by country and age.

Some older adolescents and adults may still benefit from vaccination. The potential benefit depends on previous exposure, health history, age, and local recommendations. A healthcare professional can determine whether vaccination is appropriate.

The vaccine prevents new HPV infections. It does not clear an existing infection or treat abnormal cells. Vaccinated people should follow cervical screening recommendations because screening can detect precancerous changes caused by HPV types not prevented by the vaccine or by infections acquired before vaccination.

Hepatitis B Vaccination and Liver-Cancer Prevention

Hepatitis B vaccination provides protection across the life course. Infant vaccination is especially important because infection during infancy or early childhood has a high likelihood of becoming chronic.

Unvaccinated adults may also need vaccination, especially those with increased exposure risk. Risk groups can include people with occupational blood exposure, people who inject drugs, household or sexual contacts of individuals with hepatitis B, and people receiving certain medical treatments.

Vaccination prevents new infection but does not treat chronic hepatitis B. Anyone with possible past exposure should ask about testing, even if vaccination is later recommended.

Why Vaccination Still Matters When Infection Rates Change

Outbreaks Increase the Risk of Severe Disease

Measles illustrates the broader value of vaccination. It is highly contagious and can cause pneumonia, brain inflammation, hospitalization, and death. High vaccination coverage limits transmission and helps protect infants, people with certain immune conditions, and others who cannot be vaccinated or may not respond fully.

Recent public-health reporting has emphasized the continuing risk of measles outbreaks when vaccination coverage declines (Source 4).

Measles vaccination is not presented as a direct way to prevent most infection-related cancers. Its importance lies in preventing severe disease and maintaining community protection.

Seasonal Flu Highlights the Cost of Preventable Infections

Influenza vaccination also addresses risks beyond cancer. Seasonal flu waves can cause substantial illness, hospitalization, and pressure on healthcare systems. Recent reporting has described concern about rising flu activity and the severity of some seasons (Source 5).

Flu vaccination aims to reduce severe disease and complications. It is not a direct vaccine against most infection-related cancers. It demonstrates why immunization schedules protect people from multiple health threats, not only cancer-associated infections.

What Vaccines Cannot Do

Vaccines Do Not Prevent Every Cancer

Most cancers have multiple causes. Important risk factors include:

• Tobacco use.
• Alcohol consumption.
• Excess ultraviolet exposure.
• Obesity and metabolic disease.
• Inherited genetic risk.
• Age.
• Environmental exposures.
• Chronic diseases and immune suppression.

Vaccination should therefore form one part of a broader prevention plan.

Vaccines Do Not Replace Screening

Screening can identify precancerous changes or cancer at an earlier, more treatable stage. HPV vaccination does not eliminate the need for cervical screening.

Screening recommendations vary by country, age, sex, personal history, and risk level. Follow local guidance and ask a healthcare professional whether additional screening is appropriate.

Vaccines Do Not Treat Established Cancer

HPV and hepatitis B vaccines prevent infections. They do not remove tumors or treat established cancer.

Therapeutic cancer vaccines are a separate area of medicine. Some are being studied or used in specific cancer treatments, but they should not be confused with routine preventive vaccines.

People with cancer should ask their oncology or primary-care team about vaccine timing, immune response, and safety.

How to Reduce the Risk of Infection-Related Cancer

Keep Recommended Vaccinations Up to Date

Review vaccination records with a healthcare provider or public-health service. Ask specifically about:

• HPV vaccination.
• Hepatitis B vaccination.
• Measles vaccination.
• Seasonal influenza vaccination.
• Other vaccines recommended for age, health status, travel, occupation, or local outbreaks.

Recommendations vary according to pregnancy, immune conditions, age, and country.

Seek Testing and Treatment for Persistent Infections

People with possible hepatitis B or hepatitis C exposure should ask about testing. Persistent symptoms should receive medical evaluation rather than self-diagnosis.

Effective treatment can reduce complications from some chronic infections. Follow-up may remain necessary after treatment, particularly when liver scarring or other risk factors are present.

Use Screening and Protective Behaviors

Cervical screening remains important, including for vaccinated people. Other practical measures include:

• Avoiding tobacco.
• Limiting alcohol.
• Using safer-sex practices.
• Avoiding shared needles and blood-contaminated equipment.
• Following food, water, and hygiene guidance.
• Seeking medical care for persistent or unexplained symptoms.

These actions reduce infection exposure or limit other cancer risks, but none eliminates risk entirely.

Addressing Common Vaccine-Safety Concerns

Common vaccine reactions include temporary soreness, fatigue, headache, or low-grade fever. Serious adverse reactions are uncommon, but medical advice is appropriate for concerning symptoms.

People should speak with a healthcare professional before vaccination if they have:

• A history of severe allergic reactions to a vaccine component.
• Certain immune-system conditions.
• Pregnancy, when relevant to the specific vaccine.
• A current moderate or severe illness.
• A complex medical history.

Eligibility depends on the vaccine and the individual. Official immunization guidance is more reliable than social-media claims or incomplete online summaries.

The Public-Health Importance of Cancer-Prevention Vaccines

Vaccination can reduce the chance of acquiring infections that may later contribute to cancer. Protection is generally strongest before exposure, but catch-up options may benefit some people.

High vaccination coverage also reduces transmission. Community protection helps shield infants, people with medical contraindications, and individuals who do not develop full immunity. Lower transmission can reduce long-term complications across a population.

The central message is clear: infections account for a meaningful share of cancer cases, and some of that risk is preventable. HPV and hepatitis B vaccination are the clearest vaccine-based cancer-prevention measures. They work best alongside cervical screening, infection testing, treatment, tobacco avoidance, alcohol moderation, and medical follow-up.

Ask a healthcare professional whether recommended vaccinations and cancer screenings are up to date.

Frequently Asked Questions

How can an infection cause cancer?

Some infections persist for years and create chronic inflammation, damage tissue, or interfere with normal cellular controls. Persistent infection can increase cancer risk, but infection does not mean cancer will develop.

Which vaccines help prevent cancer?

The HPV vaccine helps prevent infections that can cause cervical, anal, penile, vulvar, vaginal, and some throat cancers. The hepatitis B vaccine helps prevent chronic infection that can lead to cirrhosis and liver cancer.

Measles and flu vaccines prevent serious infectious diseases but are not presented as direct vaccines against most cancers.

Can the HPV vaccine treat an existing HPV infection?

No. The HPV vaccine prevents new infections. It does not treat an existing HPV infection, precancerous lesion, or cancer. Vaccinated people should still follow recommended cervical screening guidance.

Is there a vaccine for hepatitis C?

No widely available hepatitis C vaccine currently exists. Testing, antiviral treatment, and avoiding blood exposure are the main ways to reduce hepatitis C-related liver complications.

Do vaccinated people still need cancer screening?

Yes. Vaccination lowers the risk of specific infection-related cancers but does not prevent every cancer or every cancer-associated infection. Screening depends on age, personal history, risk factors, and local medical guidance.

What should someone do if they are unsure about vaccine status?

Review medical records, contact a healthcare provider, or consult a local public-health service. A clinician can determine whether catch-up vaccination, testing, or additional screening is appropriate.